524684-52-4 Usage
Description
Prinaberel is a potent ERβ agonist, which is a chemical compound with significant selectivity for the estrogen receptor beta (ERβ) over the estrogen receptor alpha (ERα). It is a pale yellow solid and has demonstrated its effectiveness in various applications due to its high selectivity and potency.
Uses
Used in Pharmaceutical Industry:
Prinaberel is used as a pharmaceutical agent for its potent ERβ agonist properties, displaying over 200-fold selectivity for ERβ over ERα. This makes it a valuable compound for the development of drugs targeting specific hormone receptor pathways.
Used in Hormone Receptor Research:
Prinaberel is used as a research tool in the field of hormone receptor research, particularly for studying the functions and interactions of ERβ and ERα. Its high selectivity allows for more targeted and specific investigations into the roles of these receptors in various biological processes.
Used in Drug Development:
Prinaberel is used in the development of new drugs that aim to target the ERβ receptor with high specificity. This can lead to the creation of more effective and safer medications for treating conditions related to hormone receptor imbalances or dysfunctions.
Used in Hormone Therapy:
Prinaberel, due to its potent ERβ agonist properties, can be used in hormone therapy to modulate the activity of the estrogen receptor beta. This may have potential applications in treating conditions that are influenced by the hormonal balance, such as certain types of cancer or menopausal symptoms.
Check Digit Verification of cas no
The CAS Registry Mumber 524684-52-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,2,4,6,8 and 4 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 524684-52:
(8*5)+(7*2)+(6*4)+(5*6)+(4*8)+(3*4)+(2*5)+(1*2)=164
164 % 10 = 4
So 524684-52-4 is a valid CAS Registry Number.
InChI:InChI=1/C15H10FNO3/c1-2-8-5-10(18)7-12-14(8)20-15(17-12)9-3-4-13(19)11(16)6-9/h2-7,18-19H,1H2
524684-52-4Relevant articles and documents
PHARMACEUTICAL COMPOSITIONS AND METHODS OF PREVENTING, TREATING, OR INHIBITING INFLAMMATORY DISEASES, DISORDERS, OR CONDITIONS OF THE SKIN, AND DISEASES, DISORDERS, OR CONDITIONS ASSOCIATED WITH COLLAGEN DEPLETION
-
, (2009/01/23)
The present invention provides compositions and methods for preventing, treating, or inhibiting inflammatory diseases, disorders, or conditions of the skin, and diseases, disorders, or conditions associated with collagen depletion using one or more estrogenic agents.
PHARMACEUTICAL FORMULATIONS OF AN ANHYDROUS CRYSTAL FORM OF 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL
-
Page/Page column 33, (2008/06/13)
The present invention is directed to pharmaceutical formulations of an anhydrous crystal form of an estrogen receptor modulator, and pharmaceutical compositions and preparative processes thereof.
Process for the preparation of substituted benzoxazole compounds
-
Page/Page column 6, (2008/06/13)
The present invention relates to processes for the preparation of substituted benzoxazole compounds, and in particular 2-(3-fluoro-4-hydroxy-phenyl)-7-vinyl-benzoxazol-5-ol. The processes include the vinylation of a substituted benzoxazole compound having
